The Liquid Biopsy and Tumor Progression in Breast Cancer
21 – 30 of 133
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment : a post-hoc analysis of the randomised, phase 3 SENOMAC trial
- Contribution to journal › Article
-
Mark
18 F-FDG-PET/CT in breast cancer imaging : Restaging and Implications for treatment decisions in a clinical practice setting
- Contribution to journal › Article
- 2023
-
Mark
The role of primary care in the cancer care continuum : a qualitative study of cancer survivors’ experiences
- Contribution to journal › Article
-
Mark
Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study
Gunnarsdottir, Frida Björk LU ; Bendahl, Pär Ola LU ; Johansson, Alexandra ; Benfeitas, Rui ; Rydén, Lisa LU
; Bergenfelz, Caroline
LU
and Larsson, Anna Maria
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
-
Mark
Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer : A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
- Contribution to journal › Article
-
Mark
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
Nordenskjöld, Anna ; Fohlin, Helena ; Rosell, Johan ; Bengtsson, Nils Olof ; Fornander, Tommy ; Hatschek, Thomas ; Lindman, Henrik ; Malmström, Per LU ; Rydén, Lisa LU
and Wallgren, Arne
, et al.
(2023)
In Breast
71.
p.63-68
- Contribution to journal › Article
-
Mark
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI) : a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
Lång, Kristina LU ; Josefsson, Viktoria LU ; Larsson, Anna-Maria LU ; Larsson, Stefan LU ; Högberg, Charlotte LU
; Sartor, Hanna
LU
; Hofvind, Solveig
; Andersson, Ingvar
LU
and Rosso, Aldana
LU
(2023)
In The Lancet. Oncology
24(8).
p.936-944
- Contribution to journal › Article
-
Mark
Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning : External Validation and Further Model Development
Hjärtström, Malin LU
; Dihge, Looket
LU
; Bendahl, Pär Ola
LU
; Skarping, Ida
LU
; Ellbrant, Julia
LU
; Ohlsson, Mattias
and Rydén, Lisa
LU
(2023)
In JMIR Cancer
9(1).
- Contribution to journal › Article
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
Lundgren, Christine LU ; Tutzauer, Julia LU
; Church, Sarah E.
; Stål, Olle
; Ekholm, Maria
LU
; Forsare, Carina
LU
; Nordenskjöld, Bo
; Fernö, Mårten
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
Alkner, Sara LU ; De Boniface, Jana ; Lundstedt, Dan ; Mjaaland, Ingvil ; Ryden, Lisa LU
; Vikstrom, Johan
; Bendahl, Pär Ola
LU
; Holmberg, Erik
; Sackey, Helena
and Wieslander, Elinore
, et al.
(2023)
In BMJ Open
13(9).
- Contribution to journal › Article